News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Muscle damage risk from cholesterol-lowering drug rare

16 May 2014

Serious muscle damage risk from widely used cholesterol lowering drug very low in general population: Otago research

New Zealanders taking a higher dose of simvastatin, one of the statin drugs used to prevent heart attacks and strokes, have a greater risk of rhabdomyolysis than people taking a lower dose according to new University of Otago research. However the condition, in which breakdown of muscle tissue can lead to acute kidney failure, is still very rare in both groups.

In a new study published in the journal International Journal of Cardiology, the researchers found that people taking 40mg of simvastatin daily were about five times as likely to develop rhabdomyolysis when compared with people taking 20mg daily.

In absolute terms, the risks were about 11 per 100,000 person-years in people taking 40mg simvastatin and 2 per 100,000 person-years in those taking 20mg.

Study lead investigator Dr Lianne Parkin says recent meta-analyses have clearly shown that the benefits of statins in preventing major cardiovascular events far outweigh any serious adverse effects associated with their use.

“However, these meta-analyses were based on highly selected participants in randomised controlled trials and there was very little information about the risk of rhabdomyolysis in people taking the doses of simvastatin that are recommended for use in New Zealand,” Dr Parkin says.

“While previous research has found a greater risk of serious muscle damage in people taking higher doses of statins, our study is the largest investigation to date of rhabdomyolysis in a general population of simvastatin users and the first to provide separate estimates of risk for 40mg and 20mg simvastatin.”

The researchers used routinely collected health and prescription medicine data to conduct a study based on 313,552 people of all ages who were dispensed simvastatin at any time between 2005 and 2009. Other factors, including age, sex, medical conditions, and other prescription drugs, were taken into account in the analyses.

“Statins are one of the most widely used classes of drugs,” says Dr Parkin, “and it is reassuring to have found a very low risk of rhabdomyolysis in New Zealanders using simvastatin. The greater risk associated with the use of 40mg simvastatin is one of several factors which patients and their doctors might consider when discussing the balance of benefits and risks of cholesterol-lowering treatment, and the most appropriate dose and type of statin to be used.”

The research was funded by Medsafe and the Health Research Council of New Zealand.

Publication details:
Parkin L, Paul C, Herbison GP. Simvastatin dose and risk of rhabdomyolysis: Nested case-control study based on national health and drug dispensing data.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Chris Brown: Australia/NZ Tour Cancelled

Chris Brown’s December 2015 tour in both New Zealand and Australia will not take place. Mr Brown and the promoters both remain positive that a tour will take place in the near future. More>>


Werewolf: Do You Believe In Second Chances?

Of all the great pairings of song and image during this golden age of American television we are currently enjoying – and there have been many – few have worked as powerfully and seamlessly as a moment that closed episode nine of Rectify’s second season last year. More>>


Cairns Win In Perjury Trial:

Jonah Lomu memorial:

Wellington Zoo: Endangered Golden Lion Tamarin Arrives

A new arrival has touched down at Wellington Zoo – an endangered Golden Lion Tamarin, originally from New York’s Bronx Zoo, as part of efforts to help save the species from extinction. More>>


University Of Canterbury: Henry VIII’s Divorce Lawyer’s Magna Carta On Display

The University of Canterbury is publicly displaying New Zealand’s oldest copy of the Magna Carta for the first time, just as a new connection it has with Henry VIII and Anne Boleyn has been discovered. More>>

Arts Festival: An Evening With Richard Dawkins

In a special one-off, New Zealand event at the Michael Fowler Centre, Dawkins will reflect on his eminent career as a scientist, and expand on the themes of inspiration, influence and ideas in his recent memoir, Brief Candle in the Dark: My Life in Science. More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news